Condition

Apnea

ClinicalTrials.gov condition label

Clinical trials6

Recruiting1

Common interventions12

Lead sponsors shown6

Clinical trials

6 shown

A Study to Learn About the Monthly Dosing Study Medicine Called Berobenatide in Adults With Breathing Problems During Sleep and Overweight or Obesity Who Use a Breathing Machine (PAP) (VESPER-OSA 1)NCT07823608 · 2026-09-17

Oxygen Reserve Index Predicting HypoxemiaNCT05480748 · 2022-04-01

A Study of Breathing Sound-based Classification of Patients With Breathing DisordersNCT05868694 · 2021-12-01

Effect of HFNO on Spontaneous Ventilation in Obese Patients During Analgo-sedation for VitrectomyNCT04049240 · 2019-08-01

Intraocular Pressure During Static ApneaNCT07604428 · 2018-01-01

Predictors of the Metabolic Effect of Sleep LossNCT00965783 · 2007-06-01

Common interventions

BerobenatideDRUG1 Device: High-flow nasal oxygenation (HFNO) 18<BMI<30 kg/m2DEVICE1 Device: High-flow nasal oxygenation (HFNO) 30≤BMI<35 kg/m2DEVICE1 Device: High-flow nasal oxygenation (HFNO) BMI≥35 kg/m2DEVICE1 Device: low-flow nasal oxygenation (LFNO) 18<BMI<30 kg/m2DEVICE1 Device: low-flow nasal oxygenation (LFNO) 30≤BMI<35 kg/m2DEVICE1 Device: low-flow nasal oxygenation (LFNO) BMI≥35 kg/m2DEVICE1 ExtensionOTHER1 monitoringDEVICE1 PlaceboOTHER1 polysomnographyDIAGNOSTIC_TEST1 RestrictionOTHER1

Leading sponsors

Dr. Lutfi Kirdar Kartal Training and Research Hospital1 Huai'an No.1 People's Hospital1 Pfizer1 University Hospital Olomouc1 University of Chicago1 University of Split, School of Medicine1

Trial status mix

COMPLETED3

UNKNOWN2

RECRUITING1

Phase mix

NA2

PHASE31

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.